GE Healthcare Medical Diagnostics Re-launches Optison™ Contrast Agent
Links shared publicly online about this topic.
- 965total visits
GE Healthcare Medical Diagnostics Re-launches Optison™ Contrast Agent
View full resource at medicalnewstoday.com
Tags: Imaging Tests, Ultrasound, Healthcare
Most Recently Shared on August 7, 2010 at 3:05 pm By:
GE Healthcare Medical Diagnostics Re-launches Optison™ Contrast Agent http://mnt.to/3H7y #cardiovascular
Also Shared By:
Study Supports Safety Profile Of Diagnostic Heart Ultrasound Contrast Agent Optison
medicalnewstoday.com — “GE Healthcare Medical Diagnostics has announced results of a study that evaluated the cardiopulmonary safety of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP),” View full resource at medicalnewstoday.com
Most Recently Shared on June 14, 2011 at 12:05 pm By:
Study Supports Safety Profile Of Diagnostic Heart Ultrasound Contrast Agent Optison http://mnt.to/3X94 #heart #heartdisease
GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE
news-medical.net — “Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison- (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.” View full resource at news-medical.net
Most Recently Shared on June 14, 2011 at 7:44 am By:
GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE: Today, GE Healthcar... http://bit.ly/ixkMHO
GE Healthcare Medical Diagnostics Re-launches Optison" Contrast Agent - QualityPoint Technologies
qualitypointtech.net — “GE Healthcare Medical Diagnostics announced the market reintroduction of Optison" (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not” View full resource at qualitypointtech.net
Most Recently Shared on August 7, 2010 at 11:51 am By:
GE Healthcare Medical Diagnostics Re-launches Optisonâ„¢ Contrast Agent: GE Healthcare Medical Diagnostics announc... http://bit.ly/aiXcaP
GE's Optison re-enters U.S. market
healthimaging.com — “GE Healthcare Medical Diagnostics has reintroduced Optison (Perflutren Protein-Type A Microspheres Injectable Suspension), a diagnostic ultrasound contrast agent for use in select echocardiograms.” View full resource at healthimaging.com
Most Recently Shared on July 12, 2010 at 3:41 pm By:
Health Imaging & IT Health Magazine
GE's Optison re-enters U.S. market - GE Healthcare Medical Diagnostics has reintroduced Optison (Perflutren Protein... http://ow.ly/186jby
GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms
news-medical.net — “GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison" (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing ha” View full resource at news-medical.net
Most Recently Shared on July 12, 2010 at 2:10 pm By:
GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms: GE Healthcar... http://bit.ly/czXEmp
Advertisement
MNT MRI / Ultrasound
@mnt_mri
Study Supports Safety Profile Of Diagnostic Heart Ultrasound Contrast Agent Optison http://mnt.to/3X94 #mri #pet #ultrasound
1 year ago...